共 223 条
[1]
Xia Y(2020)Global, regional and national burden of gout, 1990–2017: a systematic analysis of the global burden of disease study Baillieres Clin Rheumatol 59 1529-1538
[2]
Wu Q(2011)Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007–2008 Arthritis Rheum 63 3136-3141
[3]
Wang H(2022)Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care Nat Rev Rheumatol 18 97-111
[4]
Zhu Y(2017)2016 updated EULAR evidence-based recommendations for the management of gout Ann Rheum Dis 76 29-42
[5]
Pandya BJ(2017)Treat-to-target (T2T) recommendations for gout Ann Rheum Dis 76 632-638
[6]
Choi HK(2014)Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative Ann Rheum Dis 73 328-335
[7]
Choi HK(2014)Austrian 3e-recommendations for diagnosis and management of gout 2013 Wien Klin Wochenschr 126 79-89
[8]
McCormick N(2017)GOSPEL 3: management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century—comparison with 2006 EULAR recommendations Joint Bone Spine 84 447-453
[9]
Yokose C(2020)Recent updates on worldwide gout epidemiology Clin Rheumatol 39 1061-1063
[10]
Richette P(2007)Why is gout so poorly managed? Ann Rheum Dis 66 1269-1270